1–3 In the largest study of therapeutic outcomes in upper tract SCC, median survival was higher in those patients who received adjuvant chemotherapy, although this did not reach statistical significance (24 months vs 12 months; p = 0.56). 2 Radiographic response to neoadjuvant cisplatin-based regimens as well as irinotecan has also been reported. 3 , 4 The mean age of our cohort at the time of diagnosis was 67 years.
← all excerpts
Primary Upper Urinary Tract Small Cell Carcinoma: A Case Series and Literature Review.
1
0.5600
0.5600